What is the Difference Between Myeloma and Lymphoma?
🆚 Go to Comparative Table 🆚Myeloma and lymphoma are both cancers that affect cells in a person's blood, but they originate in different cell types and locations in the body. Here are the key differences between the two:
- Origin: Myeloma is a cancer of plasma cells, which are present in the bone marrow. Lymphoma, on the other hand, is a cancer of lymphocytes, which are white blood cells that originate in the bone marrow and are present in blood and lymph tissue.
- Location: Myeloma occurs in the cells in the bone marrow, which are responsible for making antibodies. Lymphoma typically develops in the lymph nodes, and the cancer starts growing there.
- Risk Factors: The risk factors for myeloma include being over the age of 65 years, being male, having a family history of myeloma, obesity, and other factors. Lymphoma risk factors include having a family history of the condition, having a hepatitis C infection, and having an autoimmune condition.
- Symptoms: Common symptoms of myeloma include fatigue, weakness, fever, and night sweats. Lymphoma often presents with swollen lymph nodes in the neck, armpits, or groin, dizziness, unexplained weight loss, and visual difficulties such as blurred vision.
- Treatment: Treatment options for both myeloma and lymphoma may include chemotherapy, immunotherapy, stem cell transplants, and radiation therapy. However, the specific treatment plan will depend on the stage and type of the disease.
- Outlook: The average survival time for multiple myeloma is approximately 60% at the five-year mark. The outlook for lymphoma varies depending on the type and stage of the disease, but early detection and treatment can significantly improve the prognosis.
In summary, myeloma and lymphoma are both blood cancers that affect white blood cells, but they originate in different cell types and locations in the body. The specific treatment plan and prognosis depend on the stage and type of the disease.
Comparative Table: Myeloma vs Lymphoma
Here is a table comparing the differences between multiple myeloma (MM) and lymphoma:
Feature | Multiple Myeloma | Lymphoma |
---|---|---|
Affected Cells | Plasma cells | Lymphocytes (including B and T cells) |
Location | Bone marrow | Lymph nodes and other lymph system parts |
Risk Factors | Age (over 65), gender (male), family history of MM, obesity | Age, gender, family history, certain infections |
Diagnosis | Blood tests, bone marrow biopsy, X-ray, CT scan, MRI scan | Blood tests, lymph node biopsy, X-ray, CT scan, MRI scan |
Subtypes | Light chain, non-secretory, IgM paraprotein (Waldenström's) | Hodgkin vs. non-Hodgkin, B-cell vs. T-cell |
Prevalence | Rare (about 33,700 estimated cases in the US in 2022) | More common than myeloma (about 87,790 estimated cases in the US in 2022) |
5-Year Survival | 53.9% (2022) | Higher than myeloma overall; varies by subtype |
Both multiple myeloma and lymphoma are cancers that affect blood cells, specifically plasma cells in the case of myeloma and lymphocytes in the case of lymphoma. The location where the cancer starts growing is a key difference, with myeloma developing in the bone marrow and lymphoma in the lymph nodes. Risk factors and diagnostic methods are also slightly different, but both conditions generally require blood tests, biopsies, and imaging scans for diagnosis.
- Myeloma vs Multiple Myeloma
- Leukemia vs Myeloma
- Leukemia vs Multiple Myeloma
- Leukemia vs Lymphoma
- Lymphocytic Leukemia vs Lymphoma
- CLL vs Multiple Myeloma
- Myeloblast vs Lymphoblast
- Myeloid vs Lymphoid Cells
- Smoldering Myeloma vs Multiple Myeloma
- MGUS vs Multiple Myeloma
- Lymphoma vs Non Hodgkin’s Lymphoma
- Non Hodgkin’s Lymphoma vs Leukemia
- B Cell vs T Cell Lymphoma
- Amyloidosis vs Multiple Myeloma
- Multiple Myeloma vs Waldenstrom’s Macroglobulinemia
- Hodgkin vs Non-Hodgkin Lymphoma
- Burkitt Lymphoma vs Hodgkin Lymphoma
- Bone Cancer vs Leukemia
- Myeloproliferative vs Myelodysplastic